Evidence map›Paper›PMID 41580781›Full record

ArticleCancer cell international2026

"Resolving the SCD1-oleic acid paradox: majority of oleic acid is converted to free cholesterol in colorectal cancer cells".

Aleksandra Czumaj, Jarosław Kobiela, Adriana Mika, Tomasz Sledzinski

Abstract read
In one paragraph

Article in Cancer cell international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aleksandra CzumajDepartment of Pharmaceutical Biochemistry, Faculty of Pharmacy, Medical University of Gdansk, Gdansk, 80-211, Poland.
Jarosław KobielaDepartment of Surgical Oncology, Transplant Surgery and General Surgery, Faculty of Medicine, Medical University of Gdansk, Gdansk, 80-211, Poland.
Adriana MikaDepartment of Pharmaceutical Biochemistry, Faculty of Pharmacy, Medical University of Gdansk, Gdansk, 80-211, Poland.
Tomasz SledzinskiDepartment of Pharmaceutical Biochemistry, Faculty of Pharmacy, Medical University of Gdansk, Gdansk, 80-211, Poland. tomasz.sledzinski@gumed.edu.pl.

Funding

Narodowe Centrum Nauki NCN 2016/22/E/NZ4/00665
6 · The paper itself

Abstract

objectiveThis study aimed to elucidate the mystery of “disappearing” oleic acid (OA) in colorectal cancer (CRC) cells. The primary objective was to verify if OA is predominantly used as an energy source or as a substrate for the synthesis of other molecules, given the paradox of elevated stearoyl-CoA desaturase-1 (SCD1) expression and lower OA levels in CRC tissue.

methodsTissue samples from CRC patients were analyzed for fatty acid (FA) profiles (GC-MS) and SCD1 mRNA levels (real-time PCR). For in-vitro experiments, CRC cell lines (HT-29, WiDr) and a normal human colon cell line (CCD-881-CoN) were incubated with either 13C-stearic acid (SA) or 3H-OA. GC-MS was employed to track 13C-labeled FA conversions, whereas thin-layer chromatography (TLC) followed by radioactivity measurement for 3H-labeled metabolites was utilized.

resultsTracking 13C-SA metabolism revealed its conversion to 13C-OA but also a significant “disappearance” of its metabolites from the FA pool. Experiments with 3H-OA showed that free cholesterol (FCH) was the most abundant molecule originating from 3H-OA (67–77% of redirected tritium) in CRC cells, indicating its major metabolic fate.

conclusionsThis study provides strong evidence that in CRC cells, despite SCD1 overexpression, a significant amounts of OA are converted to FCH.

Indexed as

Colorectal cancerFatty acid metabolismFree cholesterolOleic acidSCD1

Identifiers

PMID41580781
PMCPMC12910776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.